drugset / Trial / NCT07504523
Personalized T-Cell Therapy iNeo-Vac-T01 in Advanced Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to evaluate the feasibility, safety, and efficacy of personalized T-cell therapy based on tumor neoantigens in patients with advanced colorectal cancer, so as to provide a novel individualized therapeutic strategy for such patients.
Timeline
- Start
- 2023-11-01
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | iNeo-Vac-T01 | Cell therapy | — | — |